Clinical Trial

A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

Name: A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients — clinical trial record (NCT07635316)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to characterize current treatment patterns and clinical outcomes among newly diagnosed GEP-NET patients in the United States using open-source Longitudinal Prescription Claims (LRx) and Patient Centric Medical Claims (Dx) databases supplemented with mortality data.

Trial Details

NCT Number	NCT07635316
Lead Sponsor	Novartis Pharmaceuticals
Conditions	Gastroenteropancreatic Neuroendocrine Tumor
Enrollment	4,023 participants
Start Date	2026-06-12
Primary Completion	2027-02-25 (estimated)
Study Completion	2027-02-25 (estimated)
Updated on ClinicalTrials.gov	2026-06-09